Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43096 | 32578089 | MMW Fortschr Med | [Primary care diagnosis and treatment of nonalcoholic fatty liver disease]. | 2020 | Details |
| A43097 | 32576989 | Nat Rev Endocrinol | Novel regulatory pathway in NASH identified. | 2020 | Details |
| A43098 | 32571750 | Clin Res Hepatol Gastroenterol | Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis. | 2020 | Details |
| A43099 | 32571642 | Free Radic Biol Med | Corrigendum to "Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease" [Free Radic. Biol. Med. 152 (2020) 116-141]. | 2020 | Details |
| A43100 | 32564917 | Sleep Med | Obstructive sleep apnea and nonalcoholic fatty liver disease: do we need to consider this association in current clinical practice? | 2020 | Details |
| A43101 | 32562889 | Clin Gastroenterol Hepatol | Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment. | 2020 | Details |
| A43102 | 32562488 | Clin Infect Dis | Are Separate Clinical Trials Still Required in Nonalcoholic Steatohepatitis for Patients With and Without Human Immunodeficiency Virus (HIV)? | 2021 | Details |
| A43103 | 32562485 | Clin Infect Dis | Reply to Maurice and Lemoine. | 2021 | Details |
| A43104 | 32559048 | Ann Surg | Bariatric Surgery Decreases the Progression of Nonalcoholic Fatty Liver Disease to Cirrhosis. | 2020 | Details |
| A43105 | 32558697 | Eur J Gastroenterol Hepatol | COVID-19 and the liver: overview. | 2021 | Details |
| A43106 | 32558065 | Liver Int | Author response to Letter to the Editor: Potential implications of COVID-19 in non-alcoholic fatty liver disease. | 2020 | Details |
| A43107 | 32553811 | Eur J Pharmacol | The effect of emodin on liver disease -- comprehensive advances in molecular mechanisms. | 2020 | Details |
| A43108 | 32549999 | Clin Hypertens | Uric acid and cardiometabolic diseases. | 2020 | Details |
| A43109 | 32537755 | J Gastroenterol Hepatol | How do genetic variants affect our interpretation of non-invasive tests for non-alcoholic fatty liver disease? | 2020 | Details |
| A43110 | 32537135 | Clin Liver Dis (Hoboken) | Chronic Liver Disease and COVID-19: Alcohol Use Disorder/Alcohol-Associated Liver Disease, Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Autoimmune Liver Disease, and Compensated Cirrhosis. | 2020 | Details |
| A43111 | 32532017 | Int J Mol Sci | Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals. | 2020 | Details |
| A43112 | 32530998 | J Gastrointestin Liver Dis | Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited. | 2020 | Details |
| A43113 | 32530977 | J Gastrointestin Liver Dis | Nonalcoholic Fatty Liver Disease and the Need for Action. | 2020 | Details |
| A43114 | 32528225 | Clin Med Insights Case Rep | Pfeifer-Weber-Christian Disease: A Case Report and Review of Literature on Visceral Involvements and Treatment Choices. | 2020 | Details |
| A43115 | 32520360 | JAMA Netw Open | Association of Bariatric Surgery With Risk of Fracture in Patients With Severe Obesity. | 2020 | Details |
| A43116 | 32518217 | J Obes Metab Syndr | Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). | 2020 | Details |
| A43117 | 32514436 | JGH Open | Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. | 2020 | Details |
| A43118 | 32514153 | Nat Rev Gastroenterol Hepatol | NAFLD - sounding the alarm on a silent epidemic. | 2020 | Details |
| A43119 | 32513909 | Med Sci Monit | Erratum: The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43120 | 32509835 | Hepatobiliary Surg Nutr | Mediterranean diet as the ideal model for preventing non-alcoholic fatty liver disease (NAFLD). | 2020 | Details |
| A43121 | 32509834 | Hepatobiliary Surg Nutr | Non-alcoholic fatty liver disease (NAFLD) diagnosis and management-differentiating the essential from the ancillary and the present from the future. | 2020 | Details |
| A43122 | 32509828 | Hepatobiliary Surg Nutr | PNPLA3 and nonalcoholic fatty liver disease: towards personalized medicine for fatty liver. | 2020 | Details |
| A43123 | 32507608 | Eur J Intern Med | Hepatic consequences of COVID-19 infection. Lapping or biting? | 2020 | Details |
| A43124 | 32493714 | Diabetes | Phenotypic and Genetic Characterization of Lower LDL Cholesterol and Increased Type 2 Diabetes Risk in the UK Biobank. | 2020 | Details |
| A43125 | 32492166 | QJM | Response to: Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea. | 2020 | Details |
| A43126 | 32492147 | QJM | Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea. | 2020 | Details |
| A43127 | 32490551 | Hepatology | Reply. | 2020 | Details |
| A43128 | 32490323 | Hepatol Commun | Hepatic Choline Transport Is Inhibited During Fatty Acid-Induced Lipotoxicity and Obesity. | 2020 | Details |
| A43129 | 32488894 | Hepatology | Letter to the Editor: Cilofexor in Patients With Nonalcoholic Steatohepatitis (NASH): Is It Really Effective? | 2020 | Details |
| A43130 | 32485675 | J Endocrinol | RETRACTION: Leukocyte cell-derived chemotaxin 2 affects nonalcoholic fatty liver disease. | 2020 | Details |
| A43131 | 32482717 | J Lipid Res | Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings. | 2020 | Details |
| A43132 | 32479251 | Endocr Metab Immune Disord Drug Targets | Positive Correlation between Circulating Fetuin-A and Severity of Coronary Artery Disease in Men. | 2021 | Details |
| A43133 | 32478915 | J Magn Reson Imaging | Free-Breathing Volumetric Liver R 2 * and Proton Density Fat Fraction Quantification in Pediatric Patients Using Stack-of-Radial MRI With Self-Gating Motion Compensation. | 2020 | Details |
| A43134 | 32475695 | Aten Primaria | [Ultrasonography in non-alcoholic fatty liver disease]. | 2020 | Details |
| A43135 | 32471727 | J Hepatol | MARC1 variant rs2642438 increases hepatic phosphatidylcholines and decreases severity of non-alcoholic fatty liver disease in humans. | 2020 | Details |
| A43136 | 32461575 | Nat Rev Gastroenterol Hepatol | From NAFLD to MAFLD: when pathophysiology succeeds. | 2020 | Details |
| A43137 | 32454183 | Hellenic J Cardiol | Diabetes mellitus and comorbidities: A bad romance. | 2020 | Details |
| A43138 | 32445883 | J Hepatol | Lack of genetic evidence that fatty liver disease predisposes to COVID-19. | 2020 | Details |
| A43139 | 32445526 | Aliment Pharmacol Ther | Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. Authors' reply. | 2020 | Details |
| A43140 | 32445522 | Aliment Pharmacol Ther | Editorial: increasing burden of nonalcoholic fatty liver disease-a call to action. | 2020 | Details |
| A43141 | 32443199 | Environ Pollut | Lipidomics insight into chronic exposure to ambient air pollution in mice. | 2020 | Details |
| A43142 | 32442920 | Diabetes Metab Syndr | From non-alcoholic fatty liver disease (NAFLD) to metabolic-associated fatty liver disease (MAFLD): A journey over 40 years. | 2020 | Details |
| A43143 | 32440694 | Inflamm Bowel Dis | Implications of Dietary Impact on Hepatic Steatosis and IBD. | 2021 | Details |
| A43144 | 32435610 | J Transl Int Med | MiR-155 and MiR-665 Role as Potential Non-invasive Biomarkers for Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. | 2020 | Details |
| A43145 | 32431189 | J Am Heart Assoc | Fibroblast Growth Factor 21 is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Atherosclerotic Cardiovascular Events. | 2020 | Details |
| A43146 | 32431101 | Diabetes Metab J | A Comparison of Predictive Performances between Old versus New Criteria in a Risk-Based Screening Strategy for Gestational Diabetes Mellitus. | 2020 | Details |
| A43147 | 32424931 | Aliment Pharmacol Ther | Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD? Authors' reply. | 2020 | Details |
| A43148 | 32424927 | Aliment Pharmacol Ther | Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? Authors' reply. | 2020 | Details |
| A43149 | 32424922 | Aliment Pharmacol Ther | Editorial: how widespread and serious is non-alcoholic fatty liver disease in the real world? | 2020 | Details |
| A43150 | 32424917 | Aliment Pharmacol Ther | Editorial: can urine-based metabolomics improve diagnosis of advanced fibrosis in NAFLD? | 2020 | Details |
| A43151 | 32424792 | Obes Surg | Letter to the Editor Re: "Evaluation of Liver Function Tests and Risk Score Assessment to Screen Patients for Significant Liver Disease Prior to Bariatric and Metabolic Surgery". | 2020 | Details |
| A43152 | 32423633 | J Hepatol | Reply to: "Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward". | 2020 | Details |
| A43153 | 32419825 | Evid Based Complement Alternat Med | Mogroside V Protects against Hepatic Steatosis in Mice on a High-Fat Diet and LO2 Cells Treated with Free Fatty Acids via AMPK Activation. | 2020 | Details |
| A43154 | 32416974 | J Hepatol | Accurate diagnosis of NAFLD-related hepatic fibrosis with non-invasive methods: A comment for moving forward. | 2020 | Details |
| A43155 | 32414813 | Gut | Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores. | 2020 | Details |
| A43156 | 32413341 | Lancet Gastroenterol Hepatol | Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. | 2020 | Details |
| A43157 | 32410996 | Front Pharmacol | Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases-A Mini Review. | 2020 | Details |
| A43158 | 32409700 | Sci Rep | Author Correction: The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43159 | 32407814 | J Hepatol | Reply to: 'NAFLD or comorbidities, that is the question'. | 2020 | Details |
| A43160 | 32403898 | Clin Exp Pediatr | Early menarche and its consequence in Korean female: reducing fructose intake could be one solution. | 2020 | Details |
| A43161 | 32395243 | Clin Liver Dis (Hoboken) | Applications and Limitations of Noninvasive Methods for Evaluating Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43162 | 32395240 | Clin Liver Dis (Hoboken) | Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention. | 2020 | Details |
| A43163 | 32393576 | J Biol Chem | Death by lipids: The role of small nucleolar RNAs in metabolic stress. | 2020 | Details |
| A43164 | 32392372 | Liver Int | Helicobacter pylori, non-alcoholic liver disease and atrial fibrillation: Is there a link? | 2020 | Details |
| A43165 | 32391766 | Am Surg | Robotic Partial Right Hepatectomy with Pretransection Microwave Coagulation: How We Approach It. | 2020 | Details |
| A43166 | 32389909 | Nihon Shokakibyo Gakkai Zasshi | [Lifestyle-related fatty liver disease]. | 2020 | Details |
| A43167 | 32389664 | Gastroenterology | Decline in Annual Mortality of Hepatitis C Virus-Related Hepatocellular Carcinoma in the United States, From 2009 to 2018. | 2020 | Details |
| A43168 | 32387698 | J Hepatol | Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study. | 2020 | Details |
| A43169 | 32382265 | Gastroenterol Res Pract | Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients. | 2020 | Details |
| A43170 | 32380801 | J Obes Metab Syndr | Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). | 2020 | Details |
| A43171 | 32378399 | J Obes Metab Syndr | Current Long-Term Pharmacotherapies for the Management of Obesity. | 2020 | Details |
| A43172 | 32376412 | Gastroenterology | Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study. | 2020 | Details |
| A43173 | 32374328 | Biomater Sci | A versatile ultrafine and super-absorptive H+-modified montmorillonite: application for metabolic syndrome intervention and gastric mucosal protection. | 2020 | Details |
| A43174 | 32373709 | Int J Cardiol Heart Vasc | Can cysteinyl cathepsin activity control diet-induced NAFLD? | 2020 | Details |
| A43175 | 32368680 | Arch Med Sci Atheroscler Dis | Non-alcoholic fatty liver disease in patients with inflammatory bowel disease might boost cardiovascular disease burden. | 2019 | Details |
| A43176 | 32368679 | Arch Med Sci Atheroscler Dis | Lean non-alcoholic fatty liver disease: do not forget diabetes. | 2019 | Details |
| A43177 | 32360996 | J Hepatol | STELLAR 3 and STELLAR 4: Lessons from the fall of Icarus. | 2020 | Details |
| A43178 | 32360995 | J Hepatol | No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease. | 2020 | Details |
| A43179 | 32360211 | Metabolism | Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease. | 2020 | Details |
| A43180 | 32359519 | Ann Hepatol | Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease | 2020 | Details |
| A43181 | 32356701 | Med Sci (Paris) | [Intestinal bacteria involved in nutritional liver disease killed by phagotherapy: a new therapeutic target]. | 2020 | Details |
| A43182 | 32355690 | Hepatobiliary Surg Nutr | Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus? | 2020 | Details |
| A43183 | 32355686 | Hepatobiliary Surg Nutr | Modulation of the gut microbiota represents a new management for non-alcoholic fatty liver disease. | 2020 | Details |
| A43184 | 32353369 | Gastroenterology | Attribution of Nonalcoholic Steatohepatitis as an Etiology of Cirrhosis for Clinical Trials Eligibility: Recommendations From the Multi-stakeholder Liver Forum. | 2020 | Details |
| A43185 | 32353356 | Metabolism | Commentary: Obesity: The "Achilles heel" for COVID-19? | 2020 | Details |
| A43186 | 32352234 | Liver Int | Redefining fatty liver disease classification in 2020. | 2020 | Details |
| A43187 | 32351591 | Evid Based Complement Alternat Med | Effect of Moderate-Intensity Aerobic Exercise on Hepatic Fat Content and Visceral Lipids in Hepatic Patients with Diabesity: A Single-Blinded Randomised Controlled Trial. | 2020 | Details |
| A43188 | 32349649 | Curr Pharm Des | NAFLD in the 20's. From Epidemiology to Pathogenesis and Management of Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A43189 | 32342535 | Hepatology | The Metabolic Sensor Adenosine Monophosphate-Activated Protein Kinase Regulates Apoptosis in Nonalcoholic Steatohepatitis. | 2020 | Details |
| A43190 | 32338785 | Aliment Pharmacol Ther | Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? | 2020 | Details |
| A43191 | 32338780 | Aliment Pharmacol Ther | Editorial: re-thinking cardiovascular risk factors in NAFLD with advanced fibrosis? Authors' reply. | 2020 | Details |
| A43192 | 32338040 | Antioxid Redox Signal | Glycomacropeptide: A Bioactive Milk Derivative to Alleviate Metabolic Syndrome Outcomes. | 2020 | Details |
| A43193 | 32336832 | Radiol Bras | Imaging methods in the assessment of nonalcoholic fatty liver disease. | 2020 | Details |
| A43194 | 32335802 | Front Med | Biological properties and clinical applications of berberine. | 2020 | Details |
| A43195 | 32333924 | J Hepatol | NAFLD or comorbidities, that is the question. | 2020 | Details |